Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease

BACKGROUND: Serum infliximab (IFX) and antibody-to-infliximab (ATI) levels are objective parameters, that may have a great role in the therapeutic decisions during maintenance biological therapy. RESEARCH DESIGN AND METHODS: 48 inflammatory bowel disease patients receiving maintenance IFX therapy we...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Bor, Renáta, Farkas, Klaudia, Fábián, Anna, Bálint, Anita, Milassin, Ágnes, Rutka, Mariann, Matuz, Mária, Nagy, Ferenc, Szepes, Zoltán, Molnár, Tamás
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5376081/
https://ncbi.nlm.nih.gov/pubmed/28362851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172916
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia